SCHEMBL26695772

SCHEMBL26695772

COc1cc(Cl)nc(N2CCC(C(=O)ON)CC2)c1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LMNA P02545 4/20 0.60
▸ KMT2A Q03164 4/20 0.48
▸ SMN1; SMN2 Q16637 4/20 0.48
▸ MEN1 O00255 3/20 0.48
▸ TP53 P04637 1/20 0.41
▸ KDM4E B2RXH2 1/20 0.41
▸ NEK2 P51955 1/20 0.40
▸ IKBKB O14920 1/20 0.40
▸ HTT P42858 2/20 0.39
▸ CYP1A2 P05177 1/20 0.39
▸ CYP3A4 P08684 1/20 0.39
▸ CYP2C9 P11712 1/20 0.39
▸ CYP2C19 P33261 1/20 0.39
▸ ALDH1A1 P00352 1/20 0.39
▸ USP2 O75604 1/20 0.39
▸ PDE4A P27815 1/20 0.39
▸ PDE4B Q07343 1/20 0.39
▸ PDE4C Q08493 1/20 0.39
▸ PDE4D Q08499 1/20 0.39
▸ SHMT2 P34897 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26695699 0.81 LMNA (0.48) LMNAKMT2ASMN1; SMN2MEN1TP53
SCHEMBL27440444 0.79 LMNA (0.44) LMNAKMT2ASMN1; SMN2MEN1TP53
SCHEMBL29998765 0.78 LMNA (0.51) LMNAKMT2ASMN1; SMN2MEN1USP2
SCHEMBL4509698 0.75 LMNA (0.73) LMNAKMT2ASMN1; SMN2MEN1KDM4E
SCHEMBL27449378 0.74 SUV39H2 (0.53) LMNA
SCHEMBL16035866 0.72 CYP1A2 (0.56) KMT2ASMN1; SMN2MEN1TP53KDM4E
SCHEMBL4496926 0.71 LMNA (0.57) LMNAKMT2ASMN1; SMN2MEN1KDM4E
SCHEMBL17310093 0.71 SUV39H2 (0.49) LMNAKMT2ASMN1; SMN2MEN1ALDH1A1
SCHEMBL1592123 0.70 LMNA (0.56) LMNAKMT2ASMN1; SMN2MEN1KDM4E
SCHEMBL901378 0.70 LMNA (0.66) LMNAKMT2ASMN1; SMN2MEN1TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023222115-A1 HYDROXYAMIDE DERIVATIVE AND USE THEREOF 四川汇宇制药股份有限公司 2023-11-23 — — WO disclosed
Send feedback